The team that did the break-neck sequencing of the (probable?) SARS coronavirus is talking about some preliminary analysis that they’ve done. Good news/bad news: it doesn’t look much like other coronaviruses. Bad because it means we’re starting from the back tee in terms of treatment, good because it’s not like we have great treatments for the coronaviruses we know a lot about (frex, the common cold).

By the way, I said ‘(probable?)’ above because I haven’t really been keeping up with the research linking this virus to the syndrome — does anybody know how that’s looking? Any chance that this isn’t the causitive agent, or that it requires a co-factor, or anything?

Leave a comment

Please note You're welcome to use this comment form to respond to this post -- but I'd greatly prefer if you instead responded via a post on your own weblog or journal. thanks

No TrackBacks

TrackBack URL: